Skip to main content

Table 3 Incidence of proliferative lesions at the terminal sacrificea

From: Assessment of the toxicity and carcinogenicity of double-walled carbon nanotubes in the rat lung after intratracheal instillation: a two-year study

 

Untreated

Vehicle

DWCNT

0.125 mg/rat

DWCNT

0.250 mg/rat

DWCNT

0.500 mg/rat

MWCNT

0.500 mg/rat

Rats examined

21

25

25

26

24

9a

Bronchiolo-alveolar hyperplasia (BAH)

4

4

1

4

0

1

Bronchiolo-alveolar adenoma (BAA)

1

1

3

2

3

1

Bronchiolo-alveolar adenocarcinoma (BAC)

0

0

1

2

4

2

BAA + BAC

1

1

4

4

7*

3*

Malignant pleural mesothelioma

0

0

0

1b

1b

0

Malignant peritoneal mesothelioma

0

0

1

0

1

0

  1. aIn the MWCNT-7 group, 16 animals died from malignant mesothelioma after 52 weeks and before 91 weeks. Because of the invasion of the lungs by the mesotheliomas, these animals could not be accessed for development of BAH, BAA, or BAC or the site of mesothelioma development, and therefore, are not included in Table 3
  2. bThe malignant pleural mesothelioma developed in the visceral pleura
  3. *Significantly different from the vehicle group: p < 0.05 and 0.001